ATE415952T1 - Vor missbrauch geschützte opioid-haltige transdermale systeme - Google Patents

Vor missbrauch geschützte opioid-haltige transdermale systeme

Info

Publication number
ATE415952T1
ATE415952T1 AT02731653T AT02731653T ATE415952T1 AT E415952 T1 ATE415952 T1 AT E415952T1 AT 02731653 T AT02731653 T AT 02731653T AT 02731653 T AT02731653 T AT 02731653T AT E415952 T1 ATE415952 T1 AT E415952T1
Authority
AT
Austria
Prior art keywords
opioid
abuse
transdermal systems
containing transdermal
dosage form
Prior art date
Application number
AT02731653T
Other languages
English (en)
Inventor
Lino Tavares
Bruce Reidenberg
Richard Sackler
Curtis Wright
Mark A Alfonso
Benjamin Oshlack
James Cassidy
Anthony E Carpanzano
Rampurna Prasad Gullapalli
Ihor Shevchuk
Original Assignee
Euro Celtique Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euro Celtique Sa filed Critical Euro Celtique Sa
Application granted granted Critical
Publication of ATE415952T1 publication Critical patent/ATE415952T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7092—Transdermal patches having multiple drug layers or reservoirs, e.g. for obtaining a specific release pattern, or for combining different drugs
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B09—DISPOSAL OF SOLID WASTE; RECLAMATION OF CONTAMINATED SOIL
    • B09B—DISPOSAL OF SOLID WASTE
    • B09B3/00—Destroying solid waste or transforming solid waste into something useful or harmless
    • B09B3/0075—Disposal of medical waste
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B09—DISPOSAL OF SOLID WASTE; RECLAMATION OF CONTAMINATED SOIL
    • B09B—DISPOSAL OF SOLID WASTE
    • B09B2101/00—Type of solid waste
    • B09B2101/65—Medical waste
    • B09B2101/68—Transdermal patches
AT02731653T 2001-05-01 2002-04-30 Vor missbrauch geschützte opioid-haltige transdermale systeme ATE415952T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28787501P 2001-05-01 2001-05-01
US29253701P 2001-05-22 2001-05-22

Publications (1)

Publication Number Publication Date
ATE415952T1 true ATE415952T1 (de) 2008-12-15

Family

ID=26964697

Family Applications (2)

Application Number Title Priority Date Filing Date
AT08020810T ATE533478T1 (de) 2001-05-01 2002-04-30 Missbrauchssichere opioide mit transdermalen systemen
AT02731653T ATE415952T1 (de) 2001-05-01 2002-04-30 Vor missbrauch geschützte opioid-haltige transdermale systeme

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT08020810T ATE533478T1 (de) 2001-05-01 2002-04-30 Missbrauchssichere opioide mit transdermalen systemen

Country Status (11)

Country Link
US (2) US20040241218A1 (de)
EP (3) EP2316439B1 (de)
JP (3) JP5296284B2 (de)
AT (2) ATE533478T1 (de)
CY (2) CY1108821T1 (de)
DE (1) DE60230138D1 (de)
DK (3) DK2062573T3 (de)
ES (3) ES2318010T3 (de)
PT (3) PT1397095E (de)
SI (3) SI2062573T1 (de)
WO (1) WO2002087482A1 (de)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5968547A (en) 1997-02-24 1999-10-19 Euro-Celtique, S.A. Method of providing sustained analgesia with buprenorphine
US7125561B2 (en) * 2001-05-22 2006-10-24 Euro-Celtique S.A. Compartmentalized dosage form
DE10141650C1 (de) 2001-08-24 2002-11-28 Lohmann Therapie Syst Lts Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen
TW200404581A (en) 2002-04-23 2004-04-01 Alza Corp Transdermal analgesic systems with reduced abuse potential
EP1513532B1 (de) * 2002-06-10 2007-02-28 Euro-Celtique S.A. Entsorgungssysteme für transdermale abgabevorrichtungen zur verhinderung des missbrauchs von darin enthaltenen wirkstoffen
EP2422773A3 (de) * 2002-09-20 2012-04-18 Alpharma, Inc. Sequestriermitteluntereinheit und zugehörige Zusammensetzungen und Verfahren
DE10250088A1 (de) * 2002-10-25 2004-05-06 Grünenthal GmbH Gegen Missbrauch gesicherte Darreichungsform
US20040219195A1 (en) * 2003-04-30 2004-11-04 3M Innovative Properties Company Abuse-resistant transdermal dosage form
US7182955B2 (en) * 2003-04-30 2007-02-27 3M Innovative Properties Company Abuse-resistant transdermal dosage form
US8790689B2 (en) * 2003-04-30 2014-07-29 Purdue Pharma L.P. Tamper resistant transdermal dosage form
UA82880C2 (en) * 2003-04-30 2008-05-26 Tamper-resistant transdermal dosage form comprising an active agent component and an adverse agent component at the distal site of the active agent layer
AU2004261181B2 (en) * 2003-07-25 2009-08-06 Euro-Celtique S.A. Preoperative treatment of post operative pain
US20070191815A1 (en) 2004-09-13 2007-08-16 Chrono Therapeutics, Inc. Biosynchronous transdermal drug delivery
EP1677771A2 (de) * 2003-10-30 2006-07-12 Alza Corporation Transdermale analgetische systeme mit reduziertem missbrauchspotential
US8535711B2 (en) * 2004-01-23 2013-09-17 Teikoku Pharma Usa, Inc. Medication disposal system
US7867511B2 (en) * 2004-01-23 2011-01-11 Travanti Pharma Inc. Abuse potential reduction in abusable substance dosage form
EP1718258B1 (de) * 2004-02-23 2009-03-25 Euro-Celtique S.A. Missbrauchsichere transdermale abgabevorrichtung für opioide, enthaltend opioidantagonist in form von mikrokügelchen
WO2006023644A2 (en) * 2004-08-20 2006-03-02 3M Innovative Properties Company Transdermal drug delivery device with translucent protective film
US7226619B1 (en) 2004-09-07 2007-06-05 Pharmorx Inc. Material for controlling diversion of medications
US8252321B2 (en) 2004-09-13 2012-08-28 Chrono Therapeutics, Inc. Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
DK1814531T3 (da) * 2004-10-21 2010-10-11 Durect Corp Transdermale leveringssystemer
WO2006069008A1 (en) * 2004-12-22 2006-06-29 Vesta Medical, Llc Compositions and devices for inactivation of pharmaceuticals to facilitate waste disposal, and methods thereof
US20060182819A1 (en) 2005-02-17 2006-08-17 Ough Yon D Soap scent patch and treatment for muscle spasm and pain
TW200640526A (en) * 2005-02-24 2006-12-01 Alza Corp Transdermal electrotransport drug delivery systems with reduced abuse potential
PL1895994T3 (pl) 2005-05-13 2011-02-28 Alza Corp Wielowarstwowy system podawania leków z barierą zabezpieczającą przed wypływaniem materiału ze zbiornika
EP1898891A2 (de) * 2005-05-13 2008-03-19 Alza Corporation System zur verabreichung mehrschichtiger arzneimittel mit sperre gegen antagonisten
US20070014839A1 (en) * 2005-07-18 2007-01-18 Stefan Bracht Decomposer film for transdermal patches
WO2007035940A2 (en) 2005-09-23 2007-03-29 Alza Corporation Transdermal norelgestromin delivery system
EP1948142B1 (de) 2005-09-23 2014-04-09 ALZA Corporation Polyacrylatformulierung mit hoher beladung von verstärkenden substanzen für transdermale anwendungen
BRPI0619806A2 (pt) * 2005-12-13 2011-10-18 Biodelivery Sciences Int Inc dispositivo para fornecimento de fármacos transmucosal resistente ao abuso
DE102006025282A1 (de) * 2006-05-31 2007-12-20 Lts Lohmann Therapie-Systeme Ag Selbstzerstörendes transdermales therapeutisches System
SI2034975T1 (sl) 2006-06-19 2012-07-31 Alpharma Pharmaceuticals Llc Farmacevtski sestavki
US20080008747A1 (en) * 2006-07-07 2008-01-10 Royds Robert B Transdermal patch
US20100015183A1 (en) 2006-07-21 2010-01-21 Bio Delivery Sciences International ,Inc. Transmucosal delivery devices with enhanced uptake
AU2007322269A1 (en) * 2006-10-11 2008-05-29 Alpharma Pharmaceuticals, Llc Pharmaceutical compositions
US20080286348A1 (en) * 2007-05-16 2008-11-20 Todhunter John A Secured transdermal delivery system
DE102007041557B4 (de) * 2007-08-29 2011-03-31 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System enthaltend längliche Hohlkörper
US20090196890A1 (en) * 2007-12-17 2009-08-06 Alpharma Pharmaceuticals, Llc Pharmaceutical compositions
US8623418B2 (en) 2007-12-17 2014-01-07 Alpharma Pharmaceuticals Llc Pharmaceutical composition
WO2009120889A2 (en) * 2008-03-26 2009-10-01 Alltranz Inc. Abuse deterrent transdermal formulations of opiate agonists and agonist-antagonists
DE102008016804B4 (de) * 2008-04-02 2012-01-05 Lts Lohmann Therapie-Systeme Ag Selbstzerstörendes transdermales therapeutisches System mit verbesserter Funktionalität und Wirksamkeit sowie seine Verwendung
US8481560B2 (en) * 2010-04-02 2013-07-09 Alltranz Inc. Abuse deterrent transdermal formulations of opiate agonists and agonist-antagonists
EP2729148A4 (de) 2011-07-06 2015-04-22 Parkinson S Inst Zusammensetzungen und verfahren zur behandlung von symptomen bei patienten mit morbus parkinson
WO2013026064A1 (en) 2011-08-18 2013-02-21 Biodelivery Sciences International, Inc. Abuse-resistant mucoadhesive devices for delivery of buprenorphine
CN103764092A (zh) 2011-09-30 2014-04-30 帝国制药美国公司 普通药物处置系统
US8790583B2 (en) 2011-09-30 2014-07-29 Teikoku Pharma Usa, Inc. Transdermal patch disposal system
US9901539B2 (en) 2011-12-21 2018-02-27 Biodelivery Sciences International, Inc. Transmucosal drug delivery devices for use in chronic pain relief
EP3197275B1 (de) 2014-09-24 2021-11-24 Pain Therapeutics, Inc. 4: 3 naltrexon: 5-methyl-2-furaldehyd co-kristall
US10010543B1 (en) 2014-12-23 2018-07-03 Barr Laboratories, Inc. Transdermal dosage form
WO2016123406A1 (en) 2015-01-28 2016-08-04 Chrono Therapeutics Inc. Drug delivery methods and systems
US10679516B2 (en) 2015-03-12 2020-06-09 Morningside Venture Investments Limited Craving input and support system
AU2017224129B2 (en) * 2016-02-26 2022-06-30 Case Western Reserve University Composite membranes for flow batteries
AU2018205529B2 (en) 2017-01-06 2023-08-10 Morningside Venture Investments Limited Transdermal drug delivery devices and methods
US11389844B2 (en) 2018-03-20 2022-07-19 Verde Environmental Technologies, Inc. Blister pack disposal system
JP7420797B2 (ja) 2018-05-29 2024-01-23 モーニングサイド ベンチャー インベストメンツ リミテッド 薬剤送達の方法及びシステム
WO2020008366A1 (en) * 2018-07-02 2020-01-09 Clexio Biosciences Ltd. Transdermal dosage form
WO2020009685A1 (en) * 2018-07-02 2020-01-09 John Tang Transdermal dosage form
WO2020084380A1 (en) * 2018-10-23 2020-04-30 3M Innovative Properties Company Tamper evident transdermal patch
CA3150767A1 (en) * 2019-08-12 2021-02-18 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Pharmaceutical compositions comprising a combination of opioid antagonists

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3643987A1 (de) * 1986-12-22 1988-06-23 Lohmann Therapie Syst Lts Basische, wirkstoffdurchlaessige haftklebende polymermasse, insbesondere zum einsatz mit basischen wirkstoffen, verfahren zu ihrer herstellung und ihre verwendung
US5236714A (en) * 1988-11-01 1993-08-17 Alza Corporation Abusable substance dosage form having reduced abuse potential
US5028435A (en) * 1989-05-22 1991-07-02 Advanced Polymer Systems, Inc. System and method for transdermal drug delivery
US5149538A (en) * 1991-06-14 1992-09-22 Warner-Lambert Company Misuse-resistive transdermal opioid dosage form
US6096756A (en) * 1992-09-21 2000-08-01 Albert Einstein College Of Medicine Of Yeshiva University Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by morphine and other bimodally-acting opioid agonists
US5573778A (en) * 1995-03-17 1996-11-12 Adhesives Research, Inc. Drug flux enhancer-tolerant pressure sensitive adhesive composition
AU6657396A (en) * 1995-07-28 1997-02-26 Novartis Ag Transdermal system
US7011843B2 (en) * 1997-10-01 2006-03-14 Lts Lohmann-Therapie Systeme Ag Method for protecting a human being against health impairment by ingestion of a transdermal therapeutic system
IL136805A0 (en) 1997-12-22 2001-11-25 Euro Celtique Sa A method of preventing abuse of opioid dosage forms
US6554851B1 (en) * 1999-05-07 2003-04-29 Scimed Life Systems, Inc. Methods of sealing an injection site
US20040146547A1 (en) * 2001-04-23 2004-07-29 Geraldine Marcenyac Disposal system for transdermal dosage form

Also Published As

Publication number Publication date
JP2015042649A (ja) 2015-03-05
EP2316439A1 (de) 2011-05-04
CY1108821T1 (el) 2014-04-09
WO2002087482A1 (en) 2002-11-07
PT2316439E (pt) 2015-08-28
ATE533478T1 (de) 2011-12-15
SI2062573T1 (sl) 2012-02-29
DK2316439T3 (en) 2015-08-10
EP2316439B1 (de) 2015-06-17
JP2013144702A (ja) 2013-07-25
SI2316439T1 (sl) 2015-10-30
DE60230138D1 (de) 2009-01-15
JP2004529155A (ja) 2004-09-24
PT1397095E (pt) 2009-02-17
CY1112271T1 (el) 2015-12-09
ES2318010T3 (es) 2009-05-01
EP2062573B1 (de) 2011-11-16
SI1397095T1 (sl) 2009-04-30
ES2377672T3 (es) 2012-03-29
EP1397095A4 (de) 2005-05-25
EP2062573A1 (de) 2009-05-27
EP1397095B1 (de) 2008-12-03
JP5296284B2 (ja) 2013-09-25
ES2546828T3 (es) 2015-09-29
DK2062573T3 (da) 2012-01-30
US20140199383A1 (en) 2014-07-17
EP1397095A1 (de) 2004-03-17
US20040241218A1 (en) 2004-12-02
PT2062573E (pt) 2012-01-11
DK1397095T3 (da) 2009-03-09

Similar Documents

Publication Publication Date Title
ATE415952T1 (de) Vor missbrauch geschützte opioid-haltige transdermale systeme
DE60127277D1 (de) Zusammensetzung zur transdermalen und/oder transmukosalen Verabreichung von Wirkstoffen, die ausreichende therapeutische Spiegel garantiert
AU2791302A (en) Synergistic medicament containing aromatic agents and having an antagonistic, regenerative and/or protagonist decontamination effect
AU2002227913A1 (en) Synergistic medicament containing aromatic agents and having an antagonistic, regenerative and/or protagonist decontamination effect
DE60133029D1 (de) Mittel zur prävention oder behandlung von psoriasi
ES2133270T3 (es) Terapia de combinacion para la profilaxis y/o el tratamiento de hiperplasia prostatica benigna.
HUP0104709A2 (hu) Eritropoietin vagy eritropoietrinszármazékok alkalmazása agyi iszkémiák kezelésére használható gyógyszer előállítására
CY1107439T1 (el) Μεθοδοι προληψης και θεραπειας μολυνσης απο ιο του γενους flavivirus σε ζωα
BR0013009A (pt) Uso de antagonistas de cgrp e de inibidores de liberação de cgrp para combate a jatos quentes menopáusicos
FR2760972B1 (fr) Utilisation de l-citrulline en medecine orthomoleculaire pour la vasoprotection, le tonus relaxatif des muscles lisses et la protection cellulaires
ATE407695T1 (de) Tumorimpfstoff
ATE444083T1 (de) Selektives targeting von apoptotischen zellen
RS50148B (sr) Upotreba docetaksela za lečenje hepatoćelijskog karcinoma
SE0103276L (sv) Anordning för administrering av salva till en hudyta
ATE458750T1 (de) Antivirale mittel zur behandlung, kontrolle und prävention von infektionen durch coronaviren
PT1200071E (pt) Comprimidos fracamente doseados e processo de preparacao
NO20032597L (no) Anvendelse av SARP-1 for behandlingen og/eller forebyggingen av skleroderma
DK1156829T3 (da) Stabil formulering indeholdende fumagillin
WO2002028399A1 (fr) Inducteurs de l'apoptose, activateurs de cascade de caspase et agents anticancers
DK1052991T3 (da) Topisk anvendelse af loperamid til behandling af mikrobielle infektioner
CY1116853T1 (el) Διαδερμικα συστηματα οπιοειδων περισταλτικα της απροσφορης χρησης
WO2002002089A3 (de) Anthelminthika zur verhinderung von parasitären infektionen bei mensch und tier iv
TR200400812T3 (tr) KanserÁtedavisiÁiçinÁretinoidÁreseptörÁligandlarınınÁveÁseçilenÁsitotoksikÁmaddelerinÁsinerjistikÁkombinasyonları
IT243994Y1 (it) Dispositivo diffusore di sostanze deodoranti,aromatiche medicinalie/o insetticide
ITFO940008A3 (it) Protezione per la zona posteriore delle caviglie o superficie achillea per coloro che praticano il football ed altri giochi di squadra.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1397095

Country of ref document: EP